Worth reading
48Recurring
Scored from 5 of 6 sectionsDirection
Mixed performance
Direction inferred from the company’s description.Scale
34.9
Year-on-year change in operating profit (%)Wording
Conditional
How definitive the wording is.Contents of this document
Financial results presentationFiscal year ending March 20267 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥51,430 million+0.8%
Operating profit¥1,279 million-34.9%
Ordinary income¥1,642 million-26.1%
Net income¥1,111 million-28.3%
Gross Profit Margin25.1
Operating profit margin2.5
Selling, general and administrative expenses¥11,652 million
Full-year earnings forecast
Net Sales
¥54,500 million
Operating profit
¥1,500 million
Ordinary income
¥1,700 million
Profit attributable to owners of the parent
¥1,150 million
What the company explained in this material
New initiatives
- Completion of the earnings structure reform
- Qualitative growth in the food products business for commercial use
- Expansion of the Health Food and overseas businesses
- Launch of the new Health Food products GOVOCE and GOVOCE Milk
Key KPIsA metric the company considers important as a management benchmark.
- EBITDA¥2,580 million
- ROA4.1 %Year on year against the same period last yearDown
- ROIC4.2 %Year on year against the same period last yearDown
- ROE6.2 %Year on year against the same period last yearDown
- PBR0.6 timesYear on year against the same period last yearHigher
- DOE2.3 %Year on year against the same period last yearHigher
Segment results
Foodservice products
Net Sales
¥46,960 million-0.1%
Segment profit
¥2,564 million-29.8%
Health Food
Net Sales
¥4,007 million+11.8%
Segment profit
¥339 million+58.2%
Other
Net Sales
¥462 million+0.7%
Segment profit
¥57 million
Medium-term management plan targets
Plan name13th Medium-Term Management Plan
Period CoveredFiscal years ending March 2025 to March 2027
Number of employees
Number of Employees887 people
Change during the period-5 people
Capital expenditures
¥1,190 million
Annual Dividend
Annual dividend per share¥52
| Item | Details |
|---|---|
| Document type | Financial results presentation |
| Fiscal Period Covered | Fiscal year ending March 2026 |
| Net Sales | ¥51,430 million (YoY +0.8%) |
| Operating profit | ¥1,279 million (YoY -34.9%) |
| Ordinary income | ¥1,642 million (YoY -26.1%) |
| Net income | ¥1,111 million (YoY -28.3%) |
| Gross Profit Margin | 25.1 |
| Operating profit margin | 2.5 |
| Selling, general and administrative expenses | ¥11,652 million |
| Full-year earnings forecast | Net Sales ¥54,500 million / Operating profit ¥1,500 million / Ordinary income ¥1,700 million / Profit attributable to owners of the parent ¥1,150 million |
| Segment results | Foodservice products Net Sales ¥46,960 million (YoY -0.1%) / Segment profit ¥2,564 million (YoY -29.8%) / Health Food Net Sales ¥4,007 million (YoY +11.8%) / Segment profit ¥339 million (YoY +58.2%) / Other Net Sales ¥462 million (YoY +0.7%) / Segment profit ¥57 million |
| Key KPIs | Indicator name EBITDA / Value ¥2,580 million / Year on year against the same period last year Not disclosed, Indicator name ROA / Value 4.1 % / Year on year against the same period last year Down, Indicator name ROIC / Value 4.2 % / Year on year against the same period last year Down, Indicator name ROE / Value 6.2 % / Year on year against the same period last year Down, Indicator name PBR / Value 0.6 times / Year on year against the same period last year Higher, Indicator name DOE / Value 2.3 % / Year on year against the same period last year Higher |
| Number of employees | Number of Employees 887 people / Change during the period -5 people |
| Medium-term management plan targets | Plan name 13th Medium-Term Management Plan / Period Covered Fiscal years ending March 2025 to March 2027 / Target value Not disclosed |
| Annual Dividend | Annual dividend per share ¥52 / Interim and Year-End Breakdown Not disclosed |
| Capital expenditures | ¥1,190 million |
| New initiatives | Completion of the earnings structure reform, Qualitative growth in the food products business for commercial use, Expansion of the Health Food and overseas businesses, Launch of the new Health Food products GOVOCE and GOVOCE Milk |
Items this document does not state (14)
Results for the three months of the current quarterProgress against full-year forecastSelf-assessment against the planBreakdown of Factors Affecting the ChangeUnit price and quantity metricsNumber of stores and locationsAssumptions Underlying the Business OutlookRisk amount incorporated into the outlookFinancial targetsPayout ratioAcquisition of treasury sharesOrders received and order backlogMarket Size / ShareKey points of the Q&A
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.While sales volumes of sushi-roll ingredients, including food products for commercial use, declined against a backdrop of soaring prices for rice and nori seaweed, Health Food revenue increased on advertising initiatives such as television commercials and the launch of new products. On the earnings front, the persistently high price of chicken eggs, a key raw material, was a factor contributing to the decline in profit.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.